NetworkNewsBreaks – FinCanna Capital Corp. (CSE:
Post# of 30

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced the appointment of Robert “Bob” Kamm to the company’s Board of Directors. Kamm has more than 25 years of experience operating and advising businesses, including his current role representing FinCanna on the Board of Directors of its investee company, Cultivation Technologies Inc. Jeff Tindale has resigned from the FinCanna Board of Directors making way for Kamm’s appointment. Tindale will continue to serve on FinCanna’s Board of Advisors. In addition, the company announced that on August 29, 2018, it issued a total of 450,000 incentive stock options to a director and an advisor with an exercise price of $0.30 per share and a term of five years. “We are very pleased to welcome Mr. Kamm to our Board of Directors,” FinCanna Capital president and CEO Andriyko Herchak stated in the news release. “Bob has a wide range of business expertise and skills all of which will serve us well as we begin to accelerate our growth trajectory over this next time period. He has an exceptional history of identifying and building high growth companies and we look forward to him applying his talents to the future success of FinCanna. I would also like to thank Mr. Jeff Tindale for his invaluable service on our Board of Directors since FinCanna’s inception and welcome his continued involvement with FinCanna on our Board of Advisors.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

